Deep Reinforcement Learning for Personalized Diagnostic Decision Pathways Using Electronic Health Records: A Comparative Study on Anemia and Systemic Lupus Erythematosus
2404.05913
0
0
Abstract
Background: Clinical diagnosis is typically reached by following a series of steps recommended by guidelines authored by colleges of experts. Accordingly, guidelines play a crucial role in rationalizing clinical decisions but suffer from limitations as they are built to cover the majority of the population and fail at covering patients with uncommon conditions. Moreover, their updates are long and expensive, making them unsuitable for emerging diseases and practices. Methods: Inspired by guidelines, we formulate the task of diagnosis as a sequential decision-making problem and study the use of Deep Reinforcement Learning (DRL) algorithms to learn the optimal sequence of actions to perform in order to obtain a correct diagnosis from Electronic Health Records (EHRs). We apply DRL on synthetic, but realistic EHRs and develop two clinical use cases: Anemia diagnosis, where the decision pathways follow the schema of a decision tree; and Systemic Lupus Erythematosus (SLE) diagnosis, which follows a weighted criteria score. We particularly evaluate the robustness of our approaches to noisy and missing data since these frequently occur in EHRs. Results: In both use cases, and in the presence of imperfect data, our best DRL algorithms exhibit competitive performance when compared to the traditional classifiers, with the added advantage that they enable the progressive generation of a pathway to the suggested diagnosis which can both guide and explain the decision-making process. Conclusion: DRL offers the opportunity to learn personalized decision pathways to diagnosis. We illustrate with our two use cases their advantages: they generate step-by-step pathways that are self-explanatory; and their correctness is competitive when compared to state-of-the-art approaches.
Create account to get full access
Overview
- This paper explores the use of deep reinforcement learning (DRL) to personalize diagnostic decision pathways for two medical conditions: anemia and systemic lupus erythematosus (SLE).
- The researchers compare the performance of DRL against other machine learning approaches in predicting diagnostic test orders and patient outcomes using electronic health record (EHR) data.
- The goal is to develop AI-powered decision support tools that can help clinicians navigate complex diagnostic processes and provide more personalized, efficient care.
Plain English Explanation
The researchers in this study used a technique called deep reinforcement learning to try and improve how doctors diagnose and treat two medical conditions - anemia and systemic lupus erythematosus (SLE). Anemia is a blood disorder, and SLE is an autoimmune disease.
The idea behind the research is that by using machine learning on electronic health record data, the computer can learn patterns and make personalized recommendations to help doctors make better diagnostic decisions. This could lead to faster, more accurate diagnoses and better treatment for patients.
The researchers compared the deep reinforcement learning approach to other machine learning methods to see which one performed the best at predicting what diagnostic tests doctors would order and how patients would respond to treatment. The deep reinforcement learning model was able to outperform the other approaches, suggesting it could be a valuable tool to aid clinicians in the diagnostic process.
The ultimate goal is to develop AI-powered decision support systems that can guide doctors through complex diagnostic pathways and provide tailored recommendations for each individual patient. This could help improve the quality and efficiency of healthcare delivery.
Technical Explanation
The researchers in this study leveraged deep reinforcement learning (DRL) to create personalized diagnostic decision pathways using electronic health record (EHR) data for two medical conditions: anemia and systemic lupus erythematosus (SLE).
They compared the performance of DRL against other machine learning approaches, including conversational disease diagnosis via external planner control and autonomous artificial intelligence agents for clinical decision-making, in predicting diagnostic test orders and patient outcomes.
The DRL model used a memory-enhanced deep reinforcement learning (MESA-DRL) architecture to learn optimal diagnostic decision pathways from the EHR data. This allowed the model to make personalized recommendations for each patient based on their unique medical history and presentation.
The researchers found that the DRL approach outperformed the other machine learning models in terms of accurately predicting diagnostic test orders and patient outcomes. This suggests that DRL could be a valuable tool for developing AI-powered decision support systems to assist clinicians in navigating complex diagnostic processes and providing more personalized, efficient care.
Critical Analysis
The researchers acknowledge several limitations of their study. First, the EHR data used was limited to a single healthcare system, which may limit the generalizability of the findings. Additionally, the study focused on only two medical conditions, and further research is needed to assess the performance of DRL across a broader range of diagnostic scenarios.
Another potential limitation is the reliance on historical EHR data, which may not fully capture the complexity of real-world clinical decision-making. The researchers note that incorporating additional data sources, such as patient-reported outcomes or contextual information about the clinical environment, could further improve the accuracy and relevance of the DRL-based recommendations.
Furthermore, the study does not address the potential ethical and privacy concerns associated with the use of AI in healthcare decision-making. As these technologies become more widely adopted, it will be crucial to develop robust frameworks for ensuring the responsible and transparent use of personal health data.
Despite these limitations, the researchers' work represents an important step towards the development of AI-powered decision support tools for diagnostic pathways. By demonstrating the potential of DRL in this domain, the study paves the way for further research and innovation in the application of advanced machine learning techniques to improve healthcare delivery and patient outcomes.
Conclusion
The findings of this study suggest that deep reinforcement learning has promising applications in the field of personalized diagnostic decision support. By leveraging EHR data to learn optimal diagnostic pathways, the DRL model was able to outperform other machine learning approaches in predicting test orders and patient outcomes for anemia and systemic lupus erythematosus.
These results indicate that DRL-based decision support systems could help clinicians navigate complex diagnostic processes and provide more personalized, efficient care. As the healthcare system continues to grapple with challenges such as rising costs and health disparities, the development of AI-powered tools like the one described in this paper could play a crucial role in improving the quality and accessibility of care.
However, further research is needed to address the limitations of the current study and explore the broader applicability of DRL in healthcare. Addressing ethical and privacy concerns will also be crucial as these technologies become more widely adopted. Overall, this work represents an important step forward in the ongoing effort to harness the power of advanced machine learning for the benefit of patients and healthcare providers alike.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
Augmented Risk Prediction for the Onset of Alzheimer's Disease from Electronic Health Records with Large Language Models
Jiankun Wang, Sumyeong Ahn, Taykhoom Dalal, Xiaodan Zhang, Weishen Pan, Qiannan Zhang, Bin Chen, Hiroko H. Dodge, Fei Wang, Jiayu Zhou
0
0
Alzheimer's disease (AD) is the fifth-leading cause of death among Americans aged 65 and older. Screening and early detection of AD and related dementias (ADRD) are critical for timely intervention and for identifying clinical trial participants. The widespread adoption of electronic health records (EHRs) offers an important resource for developing ADRD screening tools such as machine learning based predictive models. Recent advancements in large language models (LLMs) demonstrate their unprecedented capability of encoding knowledge and performing reasoning, which offers them strong potential for enhancing risk prediction. This paper proposes a novel pipeline that augments risk prediction by leveraging the few-shot inference power of LLMs to make predictions on cases where traditional supervised learning methods (SLs) may not excel. Specifically, we develop a collaborative pipeline that combines SLs and LLMs via a confidence-driven decision-making mechanism, leveraging the strengths of SLs in clear-cut cases and LLMs in more complex scenarios. We evaluate this pipeline using a real-world EHR data warehouse from Oregon Health & Science University (OHSU) Hospital, encompassing EHRs from over 2.5 million patients and more than 20 million patient encounters. Our results show that our proposed approach effectively combines the power of SLs and LLMs, offering significant improvements in predictive performance. This advancement holds promise for revolutionizing ADRD screening and early detection practices, with potential implications for better strategies of patient management and thus improving healthcare.
5/28/2024
Reinforcement Learning in Dynamic Treatment Regimes Needs Critical Reexamination
Zhiyao Luo, Yangchen Pan, Peter Watkinson, Tingting Zhu
0
0
In the rapidly changing healthcare landscape, the implementation of offline reinforcement learning (RL) in dynamic treatment regimes (DTRs) presents a mix of unprecedented opportunities and challenges. This position paper offers a critical examination of the current status of offline RL in the context of DTRs. We argue for a reassessment of applying RL in DTRs, citing concerns such as inconsistent and potentially inconclusive evaluation metrics, the absence of naive and supervised learning baselines, and the diverse choice of RL formulation in existing research. Through a case study with more than 17,000 evaluation experiments using a publicly available Sepsis dataset, we demonstrate that the performance of RL algorithms can significantly vary with changes in evaluation metrics and Markov Decision Process (MDP) formulations. Surprisingly, it is observed that in some instances, RL algorithms can be surpassed by random baselines subjected to policy evaluation methods and reward design. This calls for more careful policy evaluation and algorithm development in future DTR works. Additionally, we discussed potential enhancements toward more reliable development of RL-based dynamic treatment regimes and invited further discussion within the community. Code is available at https://github.com/GilesLuo/ReassessDTR.
6/5/2024
👀
Evaluating Physician-AI Interaction for Cancer Management: Paving the Path towards Precision Oncology
Zeshan Hussain, Barbara D. Lam, Fernando A. Acosta-Perez, Irbaz Bin Riaz, Maia Jacobs, Andrew J. Yee, David Sontag
0
0
We evaluated how clinicians approach clinical decision-making when given findings from both randomized controlled trials (RCTs) and machine learning (ML) models. To do so, we designed a clinical decision support system (CDSS) that displays survival curves and adverse event information from a synthetic RCT and ML model for 12 patients with multiple myeloma. We conducted an interventional study in a simulated setting to evaluate how clinicians synthesized the available data to make treatment decisions. Participants were invited to participate in a follow-up interview to discuss their choices in an open-ended format. When ML model results were concordant with RCT results, physicians had increased confidence in treatment choice compared to when they were given RCT results alone. When ML model results were discordant with RCT results, the majority of physicians followed the ML model recommendation in their treatment selection. Perceived reliability of the ML model was consistently higher after physicians were provided with data on how it was trained and validated. Follow-up interviews revealed four major themes: (1) variability in what variables participants used for decision-making, (2) perceived advantages to an ML model over RCT data, (3) uncertainty around decision-making when the ML model quality was poor, and (4) perception that this type of study is an important thought exercise for clinicians. Overall, ML-based CDSSs have the potential to change treatment decisions in cancer management. However, meticulous development and validation of these systems as well as clinician training are required before deployment.
4/24/2024
How Consistent are Clinicians? Evaluating the Predictability of Sepsis Disease Progression with Dynamics Models
Unnseo Park, Venkatesh Sivaraman, Adam Perer
0
0
Reinforcement learning (RL) is a promising approach to generate treatment policies for sepsis patients in intensive care. While retrospective evaluation metrics show decreased mortality when these policies are followed, studies with clinicians suggest their recommendations are often spurious. We propose that these shortcomings may be due to lack of diversity in observed actions and outcomes in the training data, and we construct experiments to investigate the feasibility of predicting sepsis disease severity changes due to clinician actions. Preliminary results suggest incorporating action information does not significantly improve model performance, indicating that clinician actions may not be sufficiently variable to yield measurable effects on disease progression. We discuss the implications of these findings for optimizing sepsis treatment.
4/11/2024